NasdaqGS:CRTO
NasdaqGS:CRTOMedia

A Fresh Look at Criteo (CRTO) Valuation Following Xnurta’s Retail Media API Integration

The latest integration news is catching investors’ attention. Xnurta’s move to integrate Criteo (NasdaqGS:CRTO) Retail Media API brings all campaign controls into one AI-powered platform. This simplifies how advertisers work across Criteo’s network. See our latest analysis for Criteo. Criteo’s year has been anything but quiet, with integrations like Xnurta’s following hot on the heels of upbeat quarterly results. Ongoing share buybacks and new executive hires all signal active business...
NYSE:CHH
NYSE:CHHHospitality

Choice Hotels International (CHH) Is Up 6.0% After Canadian Consolidation Drives Profit Guidance Raise Has the Bull Case Changed?

On November 5, 2025, Choice Hotels International reported third-quarter results, delivering improved revenue of US$447.34 million and net income of US$180 million, reflecting strong profitability and the consolidation of its Canadian operations. The company raised its full-year profit guidance after recognizing a significant gain from acquiring full ownership in Choice Hotels Canada, highlighting international expansion as a major driver of recent performance. We’ll examine how Choice...
NasdaqGS:PTCT
NasdaqGS:PTCTBiotechs

PTC Therapeutics (PTCT) Is Up 5.1% After Return to Profitability and Strong Sephience Launch – Has The Bull Case Changed?

PTC Therapeutics recently reported a surge in third-quarter 2025 revenue to US$211.01 million and achieved net income of US$15.9 million, marking a sharp turnaround from the net loss posted a year earlier, driven by the initial success of Sephience and steady contributions from its Duchenne muscular dystrophy franchise. This financial milestone, alongside the rapid uptake of Sephience and positive feedback from healthcare providers and payers, highlights PTC Therapeutics' growing momentum in...
NasdaqGS:FTDR
NasdaqGS:FTDRConsumer Services

A Look at Frontdoor (FTDR) Valuation After Strong Q3 Results and Upgraded Revenue Guidance

Frontdoor (FTDR) released its third quarter results, highlighting higher sales and net income compared to last year. The company also updated its revenue guidance for the year. The stronger numbers and optimistic forecast have investors paying close attention. See our latest analysis for Frontdoor. After a turbulent month for Frontdoor’s share price, which is down over 23% in the last 30 days, momentum is still finding its footing, even with upbeat new earnings and a fresh CFO taking the...
NasdaqCM:SLNO
NasdaqCM:SLNOBiotechs

Soleno Therapeutics (SLNO): Rethinking Valuation After Unexpected Q3 Profit Turnaround

Soleno Therapeutics (SLNO) released its third quarter results, revealing a swing from a large net loss last year to positive net income. This change is catching the attention of investors who are eager for signs of progress. See our latest analysis for Soleno Therapeutics. That shift to positive net income may be fueling renewed investor interest, especially after Soleno’s share price jumped 9.55% in a single day despite a challenging recent stretch. While short-term momentum remains volatile...